M4Q Implementation Working Group Questions & …
1. Introduction This document is intended to provide additional guidance for the preparation of an application file in the CTD-Q format (see section 2: General Issues).
Download M4Q Implementation Working Group Questions & …
Information
Domain:
Source:
Link to this page:
Documents from same domain
ICH HARMONISED TRIPARTITE GUIDELINE
www.ich.orgGOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL INGREDIENTS ICH Harmonised Tripartite Guideline Having reached Step 4 of the ICH Process at the ICH Steering Committee meeting
Final Concept Paper Q12: Technical and Regulatory ...
www.ich.orgFINAL Q12 Concept Paper Endorsed: 9 September 2014 -3- product lifecycle management. To date, the main emphasis has been on the implementation of
Q7 Implementation Working Group ICH Q7 …
www.ich.orgInternational Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use ICH Secretariat, Chemin des Mines 9, P.O. Box 195, 1211 Geneva 20, Switzerland
GUIDELINE FOR GOOD CLINICAL PRACTICE
www.ich.orgGUIDELINE FOR GOOD CLINICAL PRACTICE INTRODUCTION Good Clinical Practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the
ICH HARMONISED GUIDELINE
www.ich.orgE6(R1) Document History First Codification History Date New Codification November 2005 E6 Approval by the Steering Committee under Step 2 and release for public consultation.
ICH HARMONISED GUIDELINE - ICH Official web …
www.ich.orginternational conference on harmonisation of technical requirements for registration of pharmaceuticals for human use ich harmonised guideline guideline for elemental impurities
![[ICH E2F] [EXAMPLE DSUR – PHASE III …](/cache/preview/1/3/5/f/e/1/c/f/thumb-135fe1cf2cdb82799c462ad0ea089c48.jpg)
[ICH E2F] [EXAMPLE DSUR – PHASE III …
www.ich.orgfictional document for illustrative purposes only document date: 5 october 2010 [ich e2f] [example dsur – phase iii investigational drug] zb3579
ADDENDUM TO ICH E11: CLINICAL INVESTIGATION …
www.ich.org3 ICH HARMONISED GUIDELINE ADDENDUM TO ICH E11: CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS IN THE PEDIATRIC POPULATION E11 (R1) ICH Consensus Guideline Released for Adoption on 18 August 2017, at Step 4 of the ICH
I ADDENDUM TO ICH E6(R1 ... - ICH Official web site
www.ich.orgi ICH HARMONISED GUIDELINE INTEGRATED ADDENDUM TO ICH E6(R1): GUIDELINE FOR GOOD CLINICAL PRACTICE ICH E6(R2) Draft ICH Consensus Guideline Released for Consultation on 11 June 2015, at Step 2 of the ICH Process
ORGANISATION OF THE COMMON TECHNICAL D …
www.ich.org1 ORGANISATION OF THE COMMON TECHNICAL DOCUMENT FOR THE REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH Harmonised Guideline Having reached Step 4 of the ICH Process at the ICH Steering Committee meeting
Related documents
Excipient Audit Guideline - IPEC Europe
ipec-europe.orgJOINT IPEC-PQG GMP AUDIT GUIDELINE FOR PHARMACEUTICAL EXCIPIENTS GUIDELINE NOTES What is the system to assure that unneeded or obsolete documents are removed from
Addressing specific regulatory excipient requirements in ...
ipec-europe.orgAddressing specific regulatory excipient requirements in the marketing authorization Dr. Philipp Hebestreit Global Regulatory Affairs Pharma Ingredients & Services
Drug-excipient interaction and its importance in dosage ...
japsonline.comJournal of Applied Pharmaceutical Science 01 (06); 2011: 66-71 ISSN: 2231 Banjara Hills, Hyderabad Pharmaceutical dosage form is a combi b. Department of Quality assurance,
Pharmaceutical Excipients: A review
www.ijapbc.comwww.ijapbc.com IJAPBC – Vol. 1(1), Jan- Mar, 2012 23 Excipients affect the physicochemical characters of the active pharmaceutical
EVALUATION OF DRUG-EXCIPIENT INTERACTION IN THE ...
www.ptfarm.plEvaluation of drug-excipient interaction in the formulation of celecoxib tablets 425 obtain 692 mg tablets. The resistance to crushing of tablets was 68 ± 1.5 N.
DEFINITION OF ACTIVE PHARMACEUTICAL INGREDIENT
www.who.intWorking document QAS/11.426/Rev.1 page 3 DEFINITION OF ACTIVE PHARMACEUTICAL INGREDIENT Background In many WHO guidelines the following definition for an active pharmaceutical ingredient
Excipient Master File Guide - ipecamericas.org
ipecamericas.orgThe International Pharmaceutical Excipients Council of the Americas Excipient Master File Guide